Hygeia Healthcare Holdings Co., Limited (HKG:6078)
13.39
+0.31 (2.37%)
Nov 3, 2025, 4:08 PM HKT
HKG:6078 Revenue
Hygeia Healthcare Holdings had revenue of 1.99B CNY in the half year ending June 30, 2025, with 13.08% growth. This brings the company's revenue in the last twelve months to 4.05B, down -13.73% year-over-year. In the year 2024, Hygeia Healthcare Holdings had annual revenue of 4.45B with 9.06% growth.
Revenue (ttm)
4.05B CNY
Revenue Growth
-13.73%
P/S Ratio
1.86
Revenue / Employee
496.25K CNY
Employees
8,169
Market Cap
8.28B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.45B | 369.44M | 9.06% |
| Dec 31, 2023 | 4.08B | 881.03M | 27.57% |
| Dec 31, 2022 | 3.20B | 880.30M | 38.02% |
| Dec 31, 2021 | 2.32B | 913.59M | 65.17% |
| Dec 31, 2020 | 1.40B | 315.94M | 29.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |